Delcam PLC
Report updated: 7th July 2004
BACKGROUND
Delcam came to the market in 1997, raising £2 million at
260p. A CADCAM specialist it had already spent two decades cementing
its reputation in the business of developing and licensing its
advanced software. It must be said that the company looked a real
class act, as, supported by a network of subsidiary companies
joint ventures and distribution agreements, sales had grown consistently
- at expanding gross margins - and had enabled the company to
be one of the top ten global players in its field, with 60% of
revenues emanating from overseas.
Switch now to the summer of 2004, and start with the recent news
that US industry analysts had voted Delcam as the number one supplier
in its field in the United States. If, like Rip Van Winkle, you
had slept for seven years and wakened up to this news, you would
be making haste to call your broker with a song in your heart.
But it would not last very long when you found out that today
the shares are just 245p.
A poor company? Absolutely not. A poor investment? Read on.
The early perception of investment quality was marred only by
the year-on-year cost of constant development expenditure, and
the perception was that even that, whilst it constituted a drogue
on the P&L, lit the path which would lead to a prosperous
future. However no assessment of Delcam is possible without recognising
that this figure runs regularly at a sum equivalent to more than
a quarter of sales.
Another problem was that the company was already a mature business,
not a concept stock - it had to make its way in the real world
and not the more clement investment environment of future promise
and breathless expectation(the latter nearly always disappointed).
And the first thing to understand here is that the company is,
and must be, totally sales-orientated, for the primal thrust of
the annual earnings stream is derived from the sale of its permanent
licenses. To be sure there are maintenance agreements, mostly
taken up, which provide a growing strand of recurrent income.
There are revenues too to be derived from installation and from
training. And whilst customers with maintenance agreements get
software upgrades as part of the deal, others do not; and of course
Delcam prospers by the sale of additional or new product to client
companies expanding their own operations, or engaging in activities
of increasing sophistication. But on the first day of January
in any given year Delcam has to conquer the world.
And what a world. Remember the sudden weakness in the Far East
which blew carefully prepared projections so smithereens? Remember
Russian devaluation? Note also how companies in the United Kingdom
have had to live with the unexpected strength of sterling; and
are now having to cope with dollar weakness.
FINANCIAL CONSEQUENCES
To be blunt, the combination of the features listed above has,
by administering regular shocks to the body corporate, robbed
Delcam of its growth cachet in its public career to date, the
nadir perhaps being that of a near £1 million restructuring
charge.
But incapacity is one thing, ill health another - and Delcam
has never suffered from that. Indeed, taken in isolation, the
figures of the three years would grace 80% or more of the total
AIM offering - a pattern of rising earnings and dividends culminating
in December 2003 sales of over £20 million, a gross margin
of £14 million, a pre-tax profit of £1.3 million and
earnings per share of over 20p. A vigorous cash flow has extinguished
the trifling borrowings.
Trouble is that the earnings figure replicated that of December
2000.
THE INVESTMENT CASE NOW
Whilst the company still relies as to about 60% of its sales
from the automobile and อากาศยาน sectors combined, customer numbers
approaching the 10,000 mark, and revenues which emanate as to
about 20% from the United Kingdom, 20% from the United States,
20% from the Far East and the bulk of the balance from Continental
Europe, point to a fine degree of stability - and a deservedly
high reputation. Some growth prospects lie in the perception of
how the awesome accumulated expertise can be packaged so as to
be adapted by hitherto lagging activities - a striking example
of this is the way in which Delcam has impacted the world of jewellery
design and manufacture. There are strong footholds in the packaging
and toy manufacturing sectors too. A bit unexpectedly to the layman
are the connections with shoe design, and contacts with Nike in
the USA are now breeding downstream sales in the countries where
the footwear is actually manufactured. A major opportunity currently
being pursued is that of working with the developers of precision
measuring equipment, opening, often, another avenue into tool
rooms round the world where Delcam is already represented - as
well as those where it is not.
Does the foregoing add up to an investment case? Maybe not, but
it is a bloody good place to start.
Delcam is capitalised at £15 million. The shares sell at
twelve-times earnings, a figure which may waft gently back into
a single-figure multiple when the 2004 earnings are eventually
tabled. Ditto, a yield of 1.5% may ratchet up to something closer
to 2%. (The interim results will be along shortly).
Some will think that dollar earners may be cherished again as
they once were.
Delcam may be in for a period of secular growth. And if conditions
do worsen, this is where gravitas speedily replaces glamour as
an object of investment desire - and note that the strengths,
including that of financial strength, would make an excellent
platform from which to acquire complementary businesses if the
price were right, almost certainly with the object of transforming
the enlarged group - the collegiate-type board tends not to fiddle
around very much.
But that is for the unknown future. Right now, seeking to undertake
the task of ploughing your savings into fertile soil, in addition
to the foregoing, you might note that in 2003, a year by no means
untypical, development expenditure outstripped the pre-tax profits
by a ratio of almost four to one.
Now that is a first class British business - and there are little
enough of them.
Courtesy of Alternative Markets Review (AMR)
- www.amreview.co.uk |